Nipun Atreja, Ph.D.
About Nipun Atreja, Ph.D.
Nipun Atreja, Ph.D., is the Director of Health Economics and Outcomes Research at Bristol Myers Squibb in New Jersey, with extensive experience in the biotechnology industry and a strong background in oncology research.
Title at Bristol Myers Squibb
Nipun Atreja, Ph.D., holds the position of Director in Health Economics and Outcomes Research at Bristol Myers Squibb. Based in New Jersey, United States, he brings a wealth of expertise in pharmaceutical health outcomes and policy to his current role.
Professional Experience at AstraZeneca
Between 2018 and 2021, Nipun Atreja, Ph.D., held key roles at AstraZeneca in the Greater Philadelphia Area. He served as the Director of Payor Evidence from 2019 to 2021 and as the Associate Director of Health Economics Outcomes Research for 10 months before that. His work focused on generating evidence to support the economic value of pharmaceutical products.
Previous Role at Alkermes
Nipun Atreja, Ph.D., has experience working at Alkermes in the Greater Boston Area. He was the Manager of Health Economics and Outcomes Research from 2017 to 2018 and served as a Consultant in the same field from 2016 to 2017. His responsibilities included conducting economic evaluations and designing research methodologies to quantify the value of therapeutic products.
Educational Background
Nipun Atreja, Ph.D., completed his Doctor of Philosophy (Ph.D.) in Pharmaceutical Health Outcomes & Policy from the University of Houston in 2016. He also holds a Master’s Degree in Pharmacy Administration from Duquesne University, which he obtained in 2011. His academic training included a strong focus on pharmacoepidemiology and economic modeling.
Expertise and Skills
Nipun Atreja, Ph.D., is skilled in pharmacoepidemiology, economic modeling, literature reviews, and patient-reported outcomes research. He has a robust background in oncology research and a demonstrated history of working within the biotechnology industry.